Back to top

LACOG 1818 – Prostate Cancer Registry

  /    /  LACOG 1818 – Prostate Cancer Registry

Survival outcomes in metastatic prostate cancer in the Brazilian population - analysis of individual characteristics and treatment modalities in different national health institutions

Type of Study: Epidemiological

Sponsor / Support: LACOG

Primary Objectives: The primary objective will be to assess cause-specific survival in patients with castration-resistant prostate cancer in different institutions in Brazil.

Design: Retrospective cohort study

Sample Size: 590 patients

Principal Investigator: Fernando Coitat Maluf

Countries LATAM: Brazil

Clinicaltrials.gov Identifier: NCT04962919

The study is open to patients participation in the following research sites:

BP - A Beneficência Portuguesa de São Paulo / São Paulo / SP / Brazil

CPO-SP - Centro de Pesquisa em Oncologia / São Paulo / SP / Brazil

Hospital Sírio-Libanês SP / São Paulo / SP / Brazil

A.C. Camargo Câncer Center / São Paulo / SP / Brazil

IGESDF / Brasília / DF / Brazil

CPO-RS - Centro de Pesquisa em Oncologia / Porto Alegre / RS / Brazil

Hospital Santa Marcelina / São Paulo / SP / Brazil

Hospital Santa Casa SP / São Paulo / SP / Brazil

CEPHO - Centro de Estudos e Pesquisa em Hematologia / Santo André / SP / Brazil

Hospital Sírio Libânes / Brasília / DF / Brazil